Ten factors were related to PRS: serum CA19-9, platelet count, tumor size, tumor number, lymph node metastasis, time to recurrence, number at recurrence, serum CA19-9 at recurrence, albumin-bilirubin (ALBI) grade at recurrence, and treatment allocation (Table 2). The gene discussed is ALB; the disease is neoplasm.